Generali Investments Management Co LLC Buys Shares of 1,407 HCA Healthcare, Inc. $HCA

Generali Investments Management Co LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 1,407 shares of the company’s stock, valued at approximately $538,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $1,021,000. Dakota Wealth Management purchased a new position in shares of HCA Healthcare during the 1st quarter valued at $221,000. Larson Financial Group LLC raised its position in shares of HCA Healthcare by 29.4% in the first quarter. Larson Financial Group LLC now owns 938 shares of the company’s stock worth $324,000 after buying an additional 213 shares in the last quarter. Graypoint LLC increased its stake in HCA Healthcare by 3.0% in the 1st quarter. Graypoint LLC now owns 1,831 shares of the company’s stock worth $633,000 after acquiring an additional 54 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its position in shares of HCA Healthcare by 75.8% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company’s stock valued at $40,000 after acquiring an additional 50 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Down 0.2%

Shares of NYSE HCA opened at $472.40 on Friday. The company has a market cap of $107.80 billion, a price-to-earnings ratio of 18.26, a PEG ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $480.00. The firm’s fifty day moving average is $433.56 and its 200 day moving average is $396.45.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is 11.13%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HCA shares. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a research note on Thursday. Bank of America raised their price target on HCA Healthcare from $430.00 to $470.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. Robert W. Baird increased their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Oppenheimer increased their price target on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. Finally, Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $474.53.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.